ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 179187 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 179187; 2) Community: the network communities that were significantly associated with the response to NSC 179187; 3) Molecule: the relationships between components within communities and NSC 179187; 4) MDR: the compounds that were significantly associated with the NSC 179187.

NSC Compound Enrichment Correlation
NSC 674276 Pyrazino[1,2-a]benzimidazole, 1,3-diphenyl- 0.0385613993886 0.37221132
NSC 685981 1,4-Butanediamine, N,N'-bis[(2-naphthalenyl)methyl- N,N'-bis[3-[(trifluoroacetyl)amino]propyl]- 0.0385613993886 -0.13373908
NSC 686660 Null 0.0385613993886 0.39562494
NSC 164991 Null 0.0385613993886001 0.285564
NSC 254665 JUSTICIDIN B 0.0385613993886001 -0.071449497
NSC 281818 Ethanol, 2,2'-[[3-methyl-4-[[[4-[2-(4-propoxyphenyl]-4-thiazolyl]phenyl]imino]methyl]phenyl]imino]bis-, dimethanesulfonate (ester) 0.0385613993886001 0.07672436
NSC 303861 L-Cysteine analog 0.0385613993886001 -0.02651867
NSC 313681 Oxiperomide(USAN) 0.0385613993886001 0.065175577
NSC 328410 Camptothecin Derivative 0.0385613993886001 0.14271409
NSC 603071 Aminocamptothecin 0.0385613993886001 0.13991869
Total:43  Current:28    [First] [Prev] [Next] [Last]